CARDIFF ONCOLOGY INC (CRDF) Stock Income Statement
NASDAQ:CRDF - Nasdaq - US14147L1089 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 588.00K | 683.00K | 488.00K | 390.00K | 360.00K | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 52.69M | 49.33M | 45.90M | 40.29M | 29.21M | |||
| Research and Development | 39.32M | 36.85M | 32.86M | 27.11M | 17.38M | |||
| Selling, General, and Administrative Expenses | 13.37M | 12.48M | 13.04M | 13.18M | 11.84M | |||
| Operating Income | -52.10M | -48.65M | -45.41M | -39.90M | -28.86M | |||
| Interest Income/Expense | 3.27M | 3.26M | 4.07M | 1.58M | 550.00K | |||
| Other Income/Expense | -28.00K | -39.00K | -98.00K | -380.00K | 20.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -48.85M | -45.43M | -41.44M | -38.70M | -28.29M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -48.88M | -45.45M | -41.47M | -38.73M | -28.32M | |||
| EBITDA | -51.70M | -48.25M | -45.01M | -39.66M | -28.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.94 | -0.95 | -0.93 | -0.89 | -0.73 | |||
| Non GAAP EPS | -0.93 | -0.95 | -0.93 | -0.89 | -0.71 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -8312.59% | -6655.20% | -8496.93% | -9930.77% | -7866.67% | |||
| Operating Profit Margin | -8860.54% | -7123.13% | -9305.74% | -10230.77% | -8016.67% | |||
All data in USD